medalphabetМедицинский алфавитMedical alphabet2078-56312949-2807ООО «Альфмед»10.33667/2078-5631-2025-23-7-10medalphabet-4632Research ArticleСтатьиСопровождение пациентов на терапии арГПП1: практические решение для косметологовPatient support during GLP‑1 arGLP‑1 therapy: practical solutions for cosmetologistshttps://orcid.org/0000-0003-0641-8232АхмедбаеваИ. А.AkhmedbaevaI. A.

Ахмедбаева Инга Александровна, к.м.н., доцент кафедры дерматовенерологии и косметологии

Москва 

Akhmedbaeva Inga A., PhD Med, associate professor at Dept of Dermatovenereology and Cosmetology 

Moscow

ingapm@yandex.ruhttps://orcid.org/0000-0002-5044-5265КругловаЛ. С.KruglovaL. S.

Круглова Лариса Сергеевна, д.м.н., профессор, заведующая кафедрой дерматовенерологии и косметологии, проректор по учебной работе

Москва 

Kruglova Larisa S., DM Sci (habil.), professor, head of Dept of Dermatovenereology and Cosmetology, vice‑rector for Academic Affairs

Moscow

kruglovals@mail.ruhttps://orcid.org/0000-0003-3437-5233ГрязеваН. В.GryazevaN. V.

Грязева Наталья Владимировна, д.м.н., профессор кафедры дерматовенерологии и косметологии

Москва 

Gryazeva Natalya V., DM Sci (habil.), professor at Dept of Dermatovenereology and Cosmetology

Moscow

tynrik@yandex.ruФГБУ ДПО «Центральная государственная медицинская академия» Управления делами Президента Российской ФедерацииРоссияCentral State Medical Academy of the Administrative Department of the President of Russian FederationRussian Federation202511112025123Дерматология (2)710Copyright © Ахмедбаева И.А., Круглова Л.С., Грязева Н.В., 20252025Ахмедбаева И.А., Круглова Л.С., Грязева Н.В.Akhmedbaeva I.A., Kruglova L.S., Gryazeva N.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-alphabet.com/jour/article/view/4632

Стратегия разработки персонализированных протоколов эстетического вмешательства пациентам, с медикаментозным снижением веса (МСВ), является актуальной задачей для врачей косметологов в нынешних реалиях, так как количество таких пациентов стремительно увеличивается, что обуславливает высокий спрос. В данной статье представлен алгоритм комплексной эстетической поддержки пациента в процессе похудения.

The strategy of developing personalized protocols of aesthetic intervention for patients with medical weight loss (MWL) is a relevant task for cosmetologists in the current realities, since the number of such patients is rapidly increasing, which causes high demand. This article presents an algorithm for comprehensive aesthetic support for a patient in the process of losing weight. 

агонисты глюкагоноподобного пептида‑1семаглутидтирзепатидпациент с медикаментозной поддержкой снижения весаglucagon‑like peptide‑1 agonistssemaglutidetirzepatidepatient with medical weight loss supportReferencesWorld Health Organization, “Obesity and Overweight”, 2024, https://www.who.int/news room/fact sheets/detail/obesity and overweight. [Ref list].World Health Organization, “Obesity and Overweight”, 2024, https://www.who.int/news room/fact sheets/detail/obesity and overweight. [Ref list].Han S.H., Safeek R., Ockerman K., et al., “Public Interest in the off Label Use of Glucagon Like Peptide 1 Agonists (Ozempic) for Cosmetic Weight Loss: A Google Trends Analysis,” Aesthetic Surgery Journal 44, no. 1 (2023): 60–67.Han S.H., Safeek R., Ockerman K., et al., “Public Interest in the off Label Use of Glucagon Like Peptide 1 Agonists (Ozempic) for Cosmetic Weight Loss: A Google Trends Analysis,” Aesthetic Surgery Journal 44, no. 1 (2023): 60–67.Государственный реестр лекарственных средств ЛП № (010345) (РГ RU) от 28.05.2025).State Register of Medicines LP No. (010345) (RG RU) dated May 28, 2025).Wilding J.P.H., Batterham R.L., Calanna S., et al. STEP 1 Study Group. Once Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18; 384 (11): 989 1002.Wilding J.P.H., Batterham R.L., Calanna S., et al. STEP 1 Study Group. Once Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021 Mar 18; 384 (11): 989 1002.Lincoff A.M., Brown Frandsen K., Colhoun H.M., et al. SELECT Trial Investigators. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023 Dec 14; 389 (24): 2221–2232.Lincoff A.M., Brown Frandsen K., Colhoun H.M., et al. SELECT Trial Investigators. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023 Dec 14; 389 (24): 2221–2232.Государственный реестр лекарственных средств (minzdrav.gov.ru), Тиретта (тирзепатид) РУ: ЛП № (008551) (PF RU) от 23.01.2025.State Register of Medicines (minzdrav.gov.ru), Tiretta (tirzepatide) RU: LP No. (008551) (PF RU) dated 23.01.2025.Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022; 24: 1553–1564.Wilding JPH, Batterham RL, Davies M, et al. Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension. Diabetes Obes Metab. 2022; 24: 1553–1564.Торшин И.Ю., Громова О.А. Проблемы использования фенола (гидроксибензола) и парабенов в качестве стабилизаторов фармацевтических средств: анализ с применением методов машинного обучения. ФАРМАКОЭКОНОМИКА. Современная фармакоэкономика и фармакоэпидемиология. 2025; 18 (1): 125–139. https://doi.org/10.17749/2070–4909/farmakoekonomika.2024.263Torshin I. Yu., Gromova O.A. Problems of using phenol (hydroxybenzene) and parabens as stabilizers of pharmaceuticals: analysis using machine learning methods. PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology. 2025; 18 (1): 125–139. (In Russ.). https://doi.org/10.17749/2070–4909/farmakoekonomika.2024.263Yao H., Zhang A., Li D., et al., “Comparative Effectiveness of GLP 1 Receptor Agonists on Glycaemic Control, Body Weight, and Lipid Profile for Type 2 Diabetes: Systematic Review and Network Meta Analysis”, BMJ 384 (2024).Yao H., Zhang A., Li D., et al., “Comparative Effectiveness of GLP 1 Receptor Agonists on Glycaemic Control, Body Weight, and Lipid Profile for Type 2 Diabetes: Systematic Review and Network Meta Analysis”, BMJ 384 (2024).Jafar A.B., Jacob J., Kao W.K., et al. Soft Tissue Facial Changes Following Massive Weight Loss Secondary to Medical and Surgical Bariatric Interventions: A Systematic Review”, Aesthetic Surgery Journal Open Forum 6 (2024).Jafar A.B., Jacob J., Kao W.K., et al. Soft Tissue Facial Changes Following Massive Weight Loss Secondary to Medical and Surgical Bariatric Interventions: A Systematic Review”, Aesthetic Surgery Journal Open Forum 6 (2024).Haykal D., Hersant B., Cartier H., et al. The Role of GLP 1 Agonists in Esthetic Medicine: Exploring the Impact of Semaglutide on Body Contouring and Skin Health J Cosmet Dermatol. 2024 Dec 8; 24 (2).Haykal D., Hersant B., Cartier H., et al. The Role of GLP 1 Agonists in Esthetic Medicine: Exploring the Impact of Semaglutide on Body Contouring and Skin Health J Cosmet Dermatol. 2024 Dec 8; 24 (2).Nikolis A., Enright K. M, Fabi S.G. et al. Consensus Statements on Managing Aesthetic Needs in Prescription Medication Driven Weight Loss Patients: An International, Multidisciplinary Delphi Study J Cosmet Dermatol. 2025 Mar 26; 24 (4).Nikolis A., Enright K. M, Fabi S.G. et al. Consensus Statements on Managing Aesthetic Needs in Prescription Medication Driven Weight Loss Patients: An International, Multidisciplinary Delphi Study J Cosmet Dermatol. 2025 Mar 26; 24 (4).Haykal D. and Cartier H., “Unveiling the Psychological and Ethical Journey of Cosmetic Dermatology Procedures,” Journal of the European Academy of Dermatology and Venereology 38 (2023).Haykal D. and Cartier H., “Unveiling the Psychological and Ethical Journey of Cosmetic Dermatology Procedures,” Journal of the European Academy of Dermatology and Venereology 38 (2023).Haykal D., “Pilot Prospective Study Evaluating the Anti Aging Efficacy, Tolerability, and Improvement of Skin Quality by Hyaluronic Acid Injections for Mid and Lower Face,” Journal of Cosmetic Dermatology 21, no. 10 (2022): 5259–5260.Haykal D., “Pilot Prospective Study Evaluating the Anti Aging Efficacy, Tolerability, and Improvement of Skin Quality by Hyaluronic Acid Injections for Mid and Lower Face,” Journal of Cosmetic Dermatology 21, no. 10 (2022): 5259–5260.Nguyen L., Blessmann M., Schneider S.W., and Herberger K., “Radiofrequency Microneedling for Skin Tightening of the Lower Face, Jawline, and Neck Region,” Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery 48, no. 12 (2022): 1299–1305.Nguyen L., Blessmann M., Schneider S.W., and Herberger K., “Radiofrequency Microneedling for Skin Tightening of the Lower Face, Jawline, and Neck Region,” Dermatologic Surgery: Official Publication for American Society for Dermatologic Surgery 48, no. 12 (2022): 1299–1305.Иконникова Е.В., Круглова Л.С., Круглова М.С. Влияние агонистов рецепторов глюкагоноподобного пептида 1 на жировую ткань лица: миф или реальность? Эффективная фармакотерапия. 2025; 21 (12): 56–60. DOI 10.33978/2307-3586-2025-21-12-56-60Ikonnikova E.V., Kruglova L.S., Kruglova M.S. The effect of glucagon like peptide 1 receptor agonists on facial adipose tissue: myth or reality? Effective Pharmacotherapy. 2025; 21 (12): 56–60. (In Russ.). DOI 10.33978/2307-3586-2025-21-12-56-60Haykal D., Cartier H., Goldberg D., and Gold M., “Advancements in Laser Technologies for Skin Rejuvenation: A Comprehensive Review of Efficacy and Safety”, Journal of Cosmetic Dermatology 23, no. 10 (2024): 3078–3089.Haykal D., Cartier H., Goldberg D., and Gold M., “Advancements in Laser Technologies for Skin Rejuvenation: A Comprehensive Review of Efficacy and Safety”, Journal of Cosmetic Dermatology 23, no. 10 (2024): 3078–3089.

The authors declare that there are no conflicts of interest present.